About 4 600 reports

A recent market study published on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022–2032. The study offers a comprehensive assessment of the more important market dynamics. After conducting thorough research on the historical and current growth parameters of the CNS Treatment and Therapy Market,...

  • Mental Health
  • Antipsychotic
  • World
  • Latin America
  • North America
  • Western Europe
  • Eastern Europe
  • Japan

The hyperhidrosis treatment market studied is anticipated to grow with a CAGR of 6.2% during the forecast period. The major factors attributing to the growth of the hyperhidrosis treatment market are a rise in the prevalence of secondary hyperhidrosis conditions and an increase in investments by players for research and development. According...

  • Dermatological Condition
  • Therapy
  • World
  • Health Expenditure
  • Diabetes Prevalence

The hematuria treatment market is projected to reach US$ 1,103.61 million by 2028 from US$ 932.89 million in 2021; it is estimated to grow at a CAGR of 2.4% from 2021 to 2028. Factors such as the high prevalence of hematuria-associated indications, and increasing awareness about treatment options and improving healthcare expenditure are driving...

  • Therapy
  • Genitourinary System Disease
  • World
  • APAC
  • Health Expenditure
  • Mortality Rate

The skincare treatment devices market is projected to reach US$ 23,378.96 million by 2028 from US$ 10,898.26 million in 2021; it is estimated to grow at a CAGR of 11.5% during 2021-2028. Increasing prevalence of skin disorders and rising awareness about beauty devices, along with increasing new product launches and rising developments...

  • Therapy
  • Skin Care
  • World
  • Disposable Income
  • Health Expenditure

The global Pigmentation Disorders Treatment Market was valued at USD 5,591.98 million in 2020, and it is expected to reach USD 8,593.68 million by 2026, registering a CAGR of 7.14% during the forecast period. The COVID-19 has impacted the pigmentation disorder treatment market. According to a survey by Hamilton Fraser Cosmetic Insurance,...

  • Therapy
  • Dermatological Condition
  • World
  • Health Expenditure
  • Number Of Enterprises

The global rotator cuff injury treatment market is projected to reach USD 1,244 million by 2026 from USD 989 million in 2021, at a CAGR of 4.7% during the forecast period”. The key factors fueling the growth of this market include an increase in sports related shoulder injuries, technological advancements in arthroscopic surgical devices,...

  • Therapy
  • World
  • United States
  • North America
  • Europe
  • APAC
  • Drug Approval
  • Sports Participation Rate

Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Exportin 1 - Drugs In Development, 2022’; Exportin 1 (Chromosome...

  • Therapy
  • Drug Development
  • World
  • Drug Approval
  • Direct Sales

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Alpha L-Iduronidase - Drugs In Development, 2022’; Alpha L-Iduronidase (IDUA or EC 3.2.1.76)...

  • Therapy
  • Endocrine Disease
  • Drug Development
  • World
  • Pharmaceutical Exports
  • Life Expectancy

The anaphylaxis treatment market is expected to reach US$ 4,787.66 million in 2028 from US$ 2,664.66 million in 2021; it is estimated to grow at a CAGR of 8.7% during 2021–2028. The growth of the market is mainly attributed to the key driving factors such as the rising incidence of anaphylaxis, and recent approvals of epinephrine. However,...

  • Therapy
  • World
  • APAC
  • Europe
  • Allergy Prevalence
  • Retail Revenue

Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) Drugs In Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Hepcidin (Liver Expressed Antimicrobial...

  • Therapy
  • World
  • Iron Export
  • Hospital Occupancy Rate

Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) - Drugs in Development, 2021 Summary Tyrosine Protein Kinase CSK (C Src Kinase or Protein Tyrosine Kinase CYL or CSK or EC 2.7.10.2) pipeline Target constitutes close to 9 molecules. Out of which approximately...

  • Pharmaceutical
  • Cancer
  • Oncology
  • Prostate Cancer
  • World
  • Drug Approval

The global prostate health market is projected to reach USD 48.9 billion by 2026 from USD 31.8 billion in 2021, at a CAGR of 9.0% during the forecast period. The prostate gland (the prostate) is an organ of the male reproductive system. The three most common forms of prostate disease are inflammation (prostatitis), non-cancerous enlargement...

  • Therapy
  • World
  • North America
  • Europe
  • United States
  • APAC
  • Overweight Prevalence
  • Health Expenditure

Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Histone Deacetylase 4 - Drugs In Development, 2022’; Histone Deacetylase...

  • Cancer
  • Therapy
  • Drug Development
  • Gene Therapy
  • Heart Failure
  • World
  • Stem Cell Transplantation

The orthopedic implant antibacterial coatings surface treatment market is expected to reach US$ 178.5 million by 2028 from US$ 87.1 million in 2021; it is estimated to register a CAGR of 10.8% from 2021 to 2028. The rise in the prevalence of implant-associated infections and technological advancements in antibacterial coatings is driving...

  • Therapy
  • Coating
  • Prosthesis
  • Orthopedics
  • Anti-Infective
  • World
  • APAC
  • Health Expenditure
  • Coating Sales

The North America non-invasive aesthetic treatment market is expected to reach US$ 8,085.74 million by 2028 from US$ 3,126.34 million in 2021; it is estimated to grow at a CAGR of 14.5% from 2021 to 2028. The growth of the market is attributed to a few key driving factors such as rising number of non-invasive aesthetic/cosmetic procedures...

  • Therapy
  • World
  • North America
  • Drug Approval
  • Cosmetic Procedures Performed

The global injection pens market is projected to reach USD 53.3 billion by 2026 from USD 37.6 billion in 2021, at a CAGR of 7.2% during the forecast period. Growing prevalence of chronic diseases, increasing number of regulatory approvals, favourable reimbursement and government support, and technological advancements in injection pens tend...

  • Diabetes
  • Therapy
  • World
  • United States
  • Europe
  • North America
  • APAC
  • Health Expenditure
  • Diabetes Prevalence

Gamma-Aminobutyric Acid Receptor Subunit Alpha 3 - Drugs In Development, 2021 Summary Gamma-Aminobutyric Acid Receptor Subunit Alpha 3 (GABA(A) Receptor Subunit Alpha 3 or GABRA3) - Gamma-aminobutyric acid A receptor, alpha 3 or GABRA3 is a protein encoded by the GABRA3 gene. GABRA3 are ligand-gated...

  • Therapy
  • Chronic Pain
  • World
  • Diagnostic Imaging Density
  • Health Provider Density

Toll Like Receptor 3 (CD283 or TLR3) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Toll Like Receptor 3 (CD283 or TLR3) - Toll-like receptor 3 (TLR3) is a protein encoded by the TLR3 gene. It controls host immune response against...

  • Therapy
  • Pharmaceutical
  • Drug Development
  • Antiviral
  • World
  • Drug Approval
  • Food Consumption

Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP) - Drugs in Development, 2021 Summary According to the recently published report ’Hepcidin - Drugs in Development, 2021’; Hepcidin (Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor...

  • Therapy
  • World
  • Iron Export
  • Hospital Occupancy Rate

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) pipeline Target constitutes...

  • Therapy
  • Dementia
  • Gene Therapy
  • World
  • Energy Supply
  • Cause-Specific Mortality Rate

Proto Oncogene Tyrosine Protein Kinase Src (Proto Oncogene c Src or pp60c src or SRC or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Proto Oncogene Tyrosine Protein Kinase...

  • Cancer
  • Lung Cancer
  • Therapy
  • Pharmaceutical
  • Biopharmaceutical
  • World
  • Taiwan
  • Cancer Mortality
  • Drug Approval

Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 - Drugs In Development, 2021 Summary Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 (GABA(A) Receptor Subunit Alpha 2 or GABRA2) pipeline Target constitutes close to 5 molecules. Out of which approximately 5 molecules are developed by Companies....

  • Therapy
  • Chronic Pain
  • World
  • Diagnostic Imaging Density

Bromodomain Containing Protein 3 (RING3 Like Protein or BRD3) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Bromodomain Containing Protein 3 - Drugs In Development, 2022’; Bromodomain...

  • Pharmaceutical
  • Therapy
  • World
  • Prescription Drug Sales
  • Medical Technology Density

The non-invasive aesthetic treatment market was valued at US$ 6,504.19 million in 2020 and is projected to reach US$ 18,656.54 million by 2028; it is expected to grow at a CAGR of 14.08% during 2020-2028. The market growth is attributed to the rising number of non-invasive aesthetic/cosmetic procedures performed every year, surge in awareness...

  • Therapy
  • World
  • APAC
  • Europe
  • Cosmetic Procedures Performed
  • Drug Approval

Male Hypogonadism Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary This latest Pharmaceutical and Healthcare disease pipeline guide Male Hypogonadism - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update,...

  • Therapy
  • Pharmaceutical
  • World
  • Egg Production

5-Hydroxytryptamine Receptor 2B - Drugs In Development, 2021 Summary 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) - 5-Hydroxytryptamine receptor 2B (5-HT2B) or serotonin receptor 2B is a protein encoded by the HTR2B gene. It plays a role in the regulation of behavior,...

  • Pharmaceutical
  • Drug Development
  • Hormone
  • World

Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Drugs In Development, 2021 Summary Cathepsin L1 (Cathepsin L or Major Excreted Protein or CTSL or EC 3.4.22.15) - Cathepsin L, a lysosomal endopeptidase is a member of the papain-like family of cysteine proteinases. Cathepsin...

  • Infectious Disease
  • Therapy
  • World

Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) - Drugs in Development, 2021 Summary Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) pipeline Target constitutes close to 7 molecules. Out of which approximately 2 molecules...

  • Oncology
  • Breast Cancer
  • Protein Therapy
  • World
  • Cause-Specific Mortality Rate
  • Drug Approval

The global neoantigens market is expected to reach US$ 10,54,783.54 thousand by 2028 from US$ 2,71,428.57 thousand in 2020. It is estimated to grow at a CAGR of 18.49% during 2020-2028. Cancer has emerged as a leading cause of death worldwide.According to the World Health Organization (WHO), cancer was the first leading cause of death...

  • Cancer
  • Therapy
  • World
  • APAC
  • Europe
  • Cancer Incidence
  • Cancer Mortality

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) pipeline Target constitutes close to 48 molecules. Out of which...

  • Cancer
  • Pharmaceutical
  • Therapy
  • World
  • Drug Approval
  • Prescription Drug Sales